CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionCurrent ratio is 12.36×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)
- FinancialsAltman Z-Score 9.12: safe zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.18%Below 5Y avg (4.98%)
Annual Rate
CNY 2.00Paid semi-annual
Payout Ratio
111.1%High
Payback Period
24.0 yr
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.63BCNY539.58M · vs all stocks (USD)
Trailing P/E
21.91xvs Medical Instruments & Supplies peers
Revenue (TTM)
892.24MCNY132.69M · vs all stocks (USD)
Profit Margin
19.99%vs Medical Instruments & Supplies peers
Beta
0.1590xvs all stocks
52-Week Change
-36.30%vs all stocks
Forward Annual Dividend Yield
4.18%vs all stocks
Market Capitalization
3.63BCNY539.58M · vs all stocks (USD)
Enterprise Value
1.43BCNY212.61M · vs all stocks (USD)
Trailing P/E
21.91xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
4.18xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.9824xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.60xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
7.54xvs Medical Instruments & Supplies peers
Gross Margin
52.92%vs Medical Instruments & Supplies peers
Profit Margin
19.99%vs Medical Instruments & Supplies peers
Operating Margin
15.44%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
2.20%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
4.55%vs Medical Instruments & Supplies peers
Revenue (TTM)
892.24MCNY132.69M · vs all stocks (USD)
Revenue per Share (TTM)
11.22CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-6.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
444.40MCNY66.09M · vs all stocks (USD)
EBITDA (TTM)
172.53MCNY25.66M · vs all stocks (USD)
Net Income (TTM)
178.37MCNY26.53M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-68.30%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
163.67MCNY24.34M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-62.34MCNY-9.27M · vs all stocks (USD)
Forward Annual Dividend Rate
2.00CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
4.18%vs all stocks
Trailing Annual Dividend Rate
2.00CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
4.18%vs all stocks
5-Year Average Dividend Yield
4.98%vs all stocks
Payout Ratio
111.11%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
-352.02KCNYFY2025 · Dec 31, 2025Revenue
905.34MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
444.09MCNYFY2025 · Dec 31, 2025Gross Profit
461.25MCNYFY2025 · Dec 31, 2025Operating Income
207.24MCNY30.82M · vs all stocks (USD)
Pre-tax Income
251.18MCNYFY2025 · Dec 31, 2025Income Tax Expense
31.10MCNYFY2025 · Dec 31, 2025Net Income
220.07MCNYFY2025 · Dec 31, 2025EBIT
251.46MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
259.81MCNYFY2025 · Dec 31, 2025Research & Development
109.32MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
76.58MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
25.49MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
280.38KCNYFY2025 · Dec 31, 2025EPS (Basic)
2.78CNYFY2025 · Dec 31, 2025EPS (Diluted)
2.78CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
79.21MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
79.21MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
220.07MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
119.99KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
137.34MCNYFY2025 · Dec 31, 2025Free Cash Flow
-81.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.06BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
220.07MCNYFY2025 · Dec 31, 2025Other Non-cash Items
15.30MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-77.63MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-218.41MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.73BCNYFY2025 · Dec 31, 2025Sale of Investments
2.08BCNYFY2025 · Dec 31, 2025Other Investing Activity
15.71MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
145.67MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-195.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
17.10MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-178.01MCNYFY2025 · Dec 31, 2025Shares Outstanding
79.28MSharesUpdated Aug 21, 2026Float Shares
27.31MSharesUpdated Aug 21, 2026% Held by Insiders
65.25%vs all stocks
% Held by Institutions
7.39%vs all stocks
Total Cash (MRQ)
2.24BCNY332.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
28.90CNYUpdated Aug 21, 2026Total Debt (MRQ)
7.35MCNY1.09M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0019xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
12.36xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
50.18CNYUpdated Aug 21, 2026Total Assets
4.24BCNY630.89M · vs all stocks (USD)
Total Current Assets
2.83BCNYFY2025 · Dec 31, 2025Total Liabilities
296.09MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.41BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
9.44MCNYFY2025 · Dec 31, 2025Total Current Liabilities
286.64MCNYFY2025 · Dec 31, 2025Cash
1.07BCNYFY2025 · Dec 31, 2025Cash Equivalents
436.74KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.07BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.32BCNYFY2025 · Dec 31, 2025Accounts Receivable
159.05MCNYFY2025 · Dec 31, 2025Inventory
176.69MCNYFY2025 · Dec 31, 2025Accounts Payable
120.05MCNYFY2025 · Dec 31, 2025Short-term Debt
544.67KCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.19MCNYFY2025 · Dec 31, 2025Long-term Debt
6.87MCNYFY2025 · Dec 31, 2025Common Stock (Book)
79.28MCNYFY2025 · Dec 31, 2025Retained Earnings
1.94BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.95BCNY586.86M · vs all stocks (USD)
Treasury Stock
47.41MCNYFY2025 · Dec 31, 202552-Week Low
39.80CNYUpdated Aug 21, 202652-Week High
76.80CNYUpdated Aug 21, 202652-Week Change
-36.30%vs all stocks
Beta
0.1590xvs all stocks
50-Day MA
44.68CNYUpdated Aug 21, 2026200-Day MA
58.07CNYUpdated Aug 21, 2026Avg 10-Day Volume
669.74KSharesUpdated Aug 21, 2026Avg 30-Day Volume
563.24KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
2.25CNYUpdated Aug 21, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 12.36×, higher than 95% of its Medical Instruments & Supplies peers (median 2.21×)Significant
Current ratio: 12.36Industry median: 2.21Industry P95: 10.51Peers compared: 65.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Financial Health
Altman Z-Score 9.12: safe zoneNotable
Altman Z-Score: 9.12
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Memsensing Microsystems Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Balu Forge Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Jasic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Senci Electric Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Shengli Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Aoto Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen CDL Precision Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ennis Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zyxel Group Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen King Explorer Science and Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Allied Supreme Corporation
3 interpretationsHigh Retained Earnings With Profitability And EquityRetained Earnings Heavy With Elevated PayoutLow-Leverage Liquidity Configuration
Luyang Energy-saving Materials Co., Ltd.
4 interpretationsHigh Retained Earnings With Profitability And EquityRetained Earnings Heavy With Elevated PayoutPrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration
Beijing SDL Technology Co. Ltd.
4 interpretationsHigh Retained Earnings With Profitability And EquityRetained Earnings Heavy With Elevated PayoutPrice Below Mean With Profitability And EquityLow-Leverage Liquidity Configuration